What Vetter Pharma’s Saarland project reveals about long-cycle CDMO investment strategies
Vetter Pharma commits €480M to build a new commercial injectable manufacturing site in Saarland, Germany; explore industry impact and CDMO capacity shifts.
Pharma & Biotech
Features & Analysis
Can EU-backed CDMO projects redefine pharma supply chains in post-industrial Europe?
The European Commission’s recent approval of €47 million in German state aid for Vetter Pharma’s new aseptic filling facility in Saarlouis marks more than a regional win. It signals a structural shift in how Europe views contract manufacturing organizations, or CDMOs—not merely as outsourcing vendors, but as core pillars of supply chain resilience, regional economic